Inborn Errors of Mucopolysaccharide Metabolism: Faulty degradative mechanisms are implicated in this group of human diseases.

The Metabolic Basis of Inherited Disease.

(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-503_7 · Cited by 7,807

Sex chromatin and gene action in the mammalian X-chromosome.

Lyon, M. F. (1962) · PubMed Central · Cited by 1,009

Hurler and Hunter Syndromes: Mutual Correction of the Defect in Cultured Fibroblasts

Fratantoni, J. C., Hall, C. W., & Neufeld, E. F. (1968) · Science · doi:10.1126/science.162.3853.570 · Cited by 446

The Abnormalities of Lysosomal Enzymes in Mucopolysaccharidoses

Hoof, F. V., & Hers, H. G. (1968) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1968.tb19570.x · Cited by 387

Formation of Three Types of Disulfated Disaccharides from Chondroitin Sulfates by Chondroitinase Digestion

Suzuki, S., Saito, H., Yamagata, T., Anno, K., Seno, N., Kawai, Y., & Furuhashi, T. (1968) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)93576-3 · Cited by 314

The defect in Hurler's and Hunter's syndromes: faulty degradation of mucopolysaccharide.

Fratantoni, J. C., Hall, C. W., & Neufeld, E. F. (1968) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.60.2.699 · Cited by 311

Über einen Typ multipler Abartungen, vorwiegend am Skelettsystem

Hurler, G. (1920) · European Journal of Pediatrics · doi:10.1007/bf02222956 · Cited by 229

Gargoylism – A mucopolysaccharidosis

Brante, G. (1952) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365515209060631 · Cited by 228

HURLER'S SYNDROME

Danes, B. S., & Bearn, A. G. (1966) · The Journal of Experimental Medicine · doi:10.1084/jem.123.1.1 · Cited by 176

Hurler's syndrome: biosynthesis of acid mucopolysaccharides in tissue culture.

Matalon, R. K., & Dorfman, A. (1966) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.56.4.1310 · Cited by 170

A Receptor-Mediated Pathway for Cholesterol Homeostasis

Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703

Biological roles of glycans

Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635

Beta glucuronidase deficiency: Report of clinical, radiologic, and biochemical features of a new mucopolysaccharidosis

Sly, W. S., Quinton, B. A., McAlister, W. H., & Rimoin, D. L. (1973) · The Journal of Pediatrics · doi:10.1016/s0022-3476(73)80162-3 · Cited by 502

Structure and Metabolism of Connective Tissue Proteoglycans

Rodén, L. (1980) · Springer eBooks · doi:10.1007/978-1-4684-1006-8_7 · Cited by 404

Gene therapy for lysosomal storage diseases

Sands, M. S., & Davidson, B. L. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.01.006 · Cited by 285

Progressive myoclonic epilepsies: a review of genetic and therapeutic aspects

Shahwan, A., Farrell, M. A., & Delanty, N. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70043-0 · Cited by 243

Reversal of pathology in murine mucopolysaccharidosis type VII by somatic cell gene transfer

Wolfe, J. H. N., Sands, M. S., Barker, J. E., Gwynn, B., Rowe, L. B., Vogler, C. A., & Birkenmeier, E. H. (1992) · Nature · doi:10.1038/360749a0 · Cited by 217

Pompe disease: from pathophysiology to therapy and back again

Lim, J., Li, L., & Raben, N. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00177 · Cited by 219

Recombinant Adeno-Associated Viral Integration and Genotoxicity: Insights from Animal Models

Chandler, R. J., Sands, M. S., & Venditti, C. P. (2017) · Human Gene Therapy · doi:10.1089/hum.2017.009 · Cited by 211

Neonatal gene transfer leads to widespread correction of pathology in a murine model of lysosomal storage disease

Daly, T. M., Vogler, C. A., Levy, B. K., Haskins, M. E., & Sands, M. S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2296 · Cited by 204

Early initiation of enzyme replacement therapy for the mucopolysaccharidoses

Muenzer, J. (2013) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2013.11.015 · Cited by 188

Induced Degradation of Glycosaminoglycans in Hurler's and Hunter's Syndromes by Plasma Infusion

Ferrante, N. D., Nichols, B. L., Donnelly, P. V., Neri, G., Hrgovcic, R., & Berglund, R. K. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.2.303 · Cited by 159

Inactivation of lysosomal function in normal cultured human fibroblasts by chloroquine

Lie, S. O., & Schofield, B. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90197-4 · Cited by 155

Transplant Outcomes in Mucopolysaccharidoses

Prasad, V. K., & Kurtzberg, J. (2009) · Seminars in Hematology · doi:10.1053/j.seminhematol.2009.10.008 · Cited by 154

CORRECTIVE FACTORS FOR INBORN ERRORS OF MUCOPOLYSACCHARIDE METABOLISM

Neufeld, E. F., & Cantz, M. (1971) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1971.tb46934.x · Cited by 153

Global gene and cell replacement strategies via stem cells

Park, K. I., Ourednik, J., Ourednik, V., Taylor, R. M., Aboody, K. S., Auguste, K. I., Lachyankar, M. B., Redmond, D. E., & Snyder, E. Y. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301721 · Cited by 147

CNS-directed AAV2-mediated gene therapy ameliorates functional deficits in a murine model of infantile neuronal ceroid lipofuscinosis

Griffey, M. A., Wozniak, D. F., Wong, M. L., Bible, E., Johnson, K. N., Rothman, S. M., Wentz, A. E., Cooper, J. D., & Sands, M. S. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.11.008 · Cited by 137

Gene therapy for lysosomal storage diseases: the lessons and promise of animal models

Ellinwood, N. M., Vite, C. H., & Haskins, M. E. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.581 · Cited by 137

Prevention of systemic clinical disease in MPS VII mice following AAV-mediated neonatal gene transfer

Daly, T., Ohlemiller, K. K., Roberts, M., Vogler, C., & Sands, M. S. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301420 · Cited by 131

Distribution of a Lysosomal Enzyme in the Adult Brain by Axonal Transport and by Cells of the Rostral Migratory Stream

Passini, M. A., Lee, E. B., Heuer, G. G., & Wolfe, J. H. N. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06437.2002 · Cited by 131

Intracranial Injection of Recombinant Adeno-associated Virus Improves Cognitive Function in a Murine Model of Mucopolysaccharidosis Type VII

Frisella, W. A., O’Connor, L. H., Vogler, C. A., Roberts, M. S., Walkley, S., Levy, B. K., Daly, T. M., & Sands, M. S. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0274 · Cited by 122

Adeno-associated virus 2-mediated gene therapy decreases autofluorescent storage material and increases brain mass in a murine model of infantile neuronal ceroid lipofuscinosis

Griffey, M. A., Bible, E., Vogler, C. A., Levy, B. K., Gupta, P. K., Cooper, J. D., & Sands, M. S. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.03.005 · Cited by 121

Functional Correction of CNS Phenotypes in a Lysosomal Storage Disease Model Using Adeno-Associated Virus Type 4 Vectors

Liu, G., Martins, I., Wemmie, J. A., Chiorini, J. A., & Davidson, B. L. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2936-05.2005 · Cited by 120

AAV2-mediated ocular gene therapy for infantile neuronal ceroid lipofuscinosis

Griffey, M., Macauley, S. L., Ogilvie, J. M., & Sands, M. S. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.04.018 · Cited by 115

Cord blood and bone marrow transplantation in inherited metabolic diseases: scientific basis, current status and future directions

Prasad, V. K., & Kurtzberg, J. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07974.x · Cited by 113

Mucopolysaccharidosis: Secondarily Induced Abnormal Distribution of Lysosomal Isoenzymes

Kint, J. A., Dacremont, G., Carton, D., Orye, E., & Hooft, C. (1973) · Science · doi:10.1126/science.181.4097.352 · Cited by 109

Evidence for Transfer of Enzyme Product as the Basis of Metabolic Cooperation between Tissue Culture Fibroblasts of Lesch-Nyhan Disease and Normal Cells

Cox, R. P., Krauss, M. R., Balis, M. E., & Dancis, J. (1970) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.67.3.1573 · Cited by 105

Prolonged expression of a lysosomal enzyme in mouse liver after Sleeping Beauty transposon‐mediated gene delivery: implications for non‐viral gene therapy of mucopolysaccharidoses

Aronovich, E. L., Bell, J. B., Belur, L. R., Günther, R., Koniar, B. L., Erickson, D. C. C., Schachern, P. A., Matise, I., McIvor, R. S., Whitley, C. B., et al. (2007) · The Journal of Gene Medicine · doi:10.1002/jgm.1028 · Cited by 104

Effect of Leukocyte Transfusion in a Child with Type II Mucopolysaccharidosis

Knudson, A. G., Ferrante, N. D., & Curtis, J. E. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.8.1738 · Cited by 100

Correction of Abnormal Cerebroside Sulfate Metabolism in Cultured Metachromatic Leukodystrophy Fibroblasts

Porter, M. T., Fluharty, A. L., & Kihara, H. (1971) · Science · doi:10.1126/science.172.3989.1263 · Cited by 99

Critical Issues in Gene Therapy for Neurologic Disease

Hsich, G. E., Sena‐Esteves, M., & Breakefield, X. O. (2002) · Human Gene Therapy · doi:10.1089/10430340252837198 · Cited by 98

The Chondrodystrophies

Rimoin, D. L. (1975) · Springer eBooks · doi:10.1007/978-1-4615-9068-2_1 · Cited by 92

AAV Vector-Mediated Correction of Brain Pathology in a Mouse Model of Niemann–Pick A Disease

Passini, M. A., Macauley, S. L., Huff, M. R., Taksir, T. V., Bu, J., Wu, I., Piepenhagen, P. A., Dodge, J. C., Shihabuddin, L. S., O’Riordan, C. R., et al. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.01.011 · Cited by 90

The Systemic Mucopolysaccharidoses

Spranger, J. W. (1972) · Springer eBooks · doi:10.1007/978-3-642-65300-1_4 · Cited by 84

Krabbe disease: New hope for an old disease

Bradbury, A. M., Bongarzone, E. R., & Sands, M. S. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.135841 · Cited by 83

Therapeutic Approaches in Glycogen Storage Disease Type II/Pompe Disease

Schoser, B. G. H., Hill, V. K., & Raben, N. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.08.009 · Cited by 83

Widespread correction of central nervous system disease after intracranial gene therapy in a feline model of Sandhoff disease

McCurdy, V. J., Rockwell, H. E., Arthur, J. R., Bradbury, A. M., Johnson, A. K., Randle, A. N., Brunson, B. L., Hwang, M., Gray‐Edwards, H. L., Morrison, N. E., et al. (2014) · Gene Therapy · doi:10.1038/gt.2014.108 · Cited by 79

Complete Correction of Enzymatic Deficiency and Neurochemistry in the GM1-gangliosidosis Mouse Brain by Neonatal Adeno-associated Virus–mediated Gene Delivery

Broekman, M. L. D., Baek, R. C., Comer, L. A., Fernandez, J. L., Seyfried, T. N., & Sena‐Esteves, M. (2006) · Molecular Therapy · doi:10.1038/sj.mt.6300004 · Cited by 79

Intravitreal Gene Therapy Reduces Lysosomal Storage in Specific Areas of the CNS in Mucopolysaccharidosis VII Mice

Hennig, A. K., Levy, B. K., Ogilvie, J. M., Vogler, C. A., Galvin, N. J., Bassnett, S., & Sands, M. S. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-08-03302.2003 · Cited by 79

Occurrence of multiple dentigerous cysts in a patient with the Maroteaux-Lamy syndrome (mucopolysaccharidosis, type VI)

Roberts, M. W., Barton, N. W., Constantopoulos, G., Butler, D. P., & Donahue, A. H. (1984) · Oral Surgery Oral Medicine Oral Pathology · doi:10.1016/0030-4220(84)90133-6 · Cited by 79

Scheie and Hurler Syndromes: Apparent Identity of the Biochemical Defect

WIESMANN, U. N., & Neufeld, E. F. (1970) · Science · doi:10.1126/science.169.3940.72 · Cited by 77

Slowing late infantile Batten disease by direct brain parenchymal administration of a rh.10 adeno-associated virus expressing CLN2

Sondhi, D., Kaminsky, S. M., Hackett, N. R., Pagovich, O. E., Rosenberg, J. B., De, B. P., Chen, A., Van de Graaf, B., Mezey, J. G., Mammen, G. W., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.abb5413 · Cited by 72

Biodistribution, Kinetics, and Efficacy of Highly Phosphorylated and Non-phosphorylated β-Glucuronidase in the Murine Model of Mucopolysaccharidosis VII

Sands, M. S., Vogler, C. A., Ohlemiller, K. K., Roberts, M. S., Grubb, J. H., Levy, B. K., & Sly, W. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107778200 · Cited by 72

Sustained Normalization of Neurological Disease after Intracranial Gene Therapy in a Feline Model

McCurdy, V. J., Johnson, A. K., Gray‐Edwards, H. L., Randle, A. N., Brunson, B. L., Morrison, N. E., Salibi, N., Johnson, J. A., Hwang, M., Beyers, R. J., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007733 · Cited by 67

The Feline Genome Project

O’Brien, S. J., Menotti-Raymond, M. A., Murphy, W. J., & Yuhki, N. (2002) · Annual Review of Genetics · doi:10.1146/annurev.genet.36.060602.145553 · Cited by 71

CNS‐directed gene therapy for lysosomal storage diseases

Sands, M. S., & Haskins, M. E. (2008) · Acta Paediatrica · doi:10.1111/j.1651-2227.2008.00660.x · Cited by 68

Possible role of autoantibodies in the pathophysiology of GM2 gangliosidoses

Yamaguchi, A., Katsuyama, K., Nagahama, K., Takai, T., Aoki, I., & Yamanaka, S. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200419639 · Cited by 68

The production of lysyl oxidase by human fibroblasts in culture

Layman, D. L., Narayanan, A. S., & Martin, G. R. (1972) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(72)90302-5 · Cited by 68

Restoration of normal lysosomal function in mucopolysaccharidosis type VII cells by retroviral vector-mediated gene transfer.

Wolfe, J. H. N., Schuchman, E. H., Stramm, L. E., Concaugh, E. A., Haskins, M. E., Aguirre, G. K., Patterson, D. F., Desnick, R. J., & Gilboa, E. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.8.2877 · Cited by 67

Oligodendroglial Progenitor Cell Therapy Limits Central Neurological Deficits in Mice with Metachromatic Leukodystrophy

Givogri, M. I., Galbiati, F., Fasano, S., Amadio, S., Perani, L., Superchi, D., Morana, P., Carro, U. D., Marchesini, S., Brambilla, R., et al. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.4366-05.2006 · Cited by 66

A Receptor‐Mediated Pathway for Cholesterol Homeostasis (Nobel Lecture)

Brown, M. S., & Goldstein, J. L. (1986) · Angewandte Chemie International Edition in English · doi:10.1002/anie.198605833 · Cited by 66

Genetic Screening

Levy, H. L. (1973) · Springer eBooks · doi:10.1007/978-1-4615-8261-8_1 · Cited by 66

Combination therapies for lysosomal storage disease: is the whole greater than the sum of its parts?

Hawkins-Salsbury, J. A., Reddy, A. S., & Sands, M. S. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr112 · Cited by 65

Synergistic effects of treating the spinal cord and brain in CLN1 disease

Shyng, C., Nelvagal, H. R., Dearborn, J. T., Tyynelä, J., Schmidt, R. E., Sands, M. S., & Cooper, J. D. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1701832114 · Cited by 65

Ocular Pathology of the Maroteaux-Lamy Syndrome (Systemic Mucopolysaccharidosis Type VI)

Kenyon, K. R., Topping, T. M., Green, W. R., & Maumenee, A. E. (1972) · American Journal of Ophthalmology · doi:10.1016/0002-9394(72)90390-x · Cited by 65

Presentation and treatments for Mucopolysaccharidosis Type II (MPS II; Hunter Syndrome)

Stapleton, M., Kubaski, F., Mason, R. W., Yabe, H., Suzuki, Y., Orii, K. E., Orii, T., & Tomatsu, S. (2017) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2017.1296761 · Cited by 64

Therapeutic Approaches to the Challenge of Neuronal Ceroid Lipofuscinoses

Kohan, R., Cismondi, I. A., Ramírez, A. M. O., Guelbert, N. B., Anzolini, V. T., Alonso, G., Mole, S., de Kremer, R. D., & de Halac, I. N. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111795542633 · Cited by 61

Chemical and metabolic heterogeneity of chondroitin sulfate and keratan sulfate in guinea pig cartilage and nucleus pulposus

Lohmander, S. L., ANTONOPOULOS, C. A., & Friberg, U. (1973) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(73)90263-8 · Cited by 62

Gene Therapy for Lysosomal Storage Diseases (LSDs) in Large Animal Models

Haskins, M. E. (2009) · ILAR Journal · doi:10.1093/ilar.50.2.112 · Cited by 61

Lysosomal diseases: Overview on current diagnosis and treatment

Poswar, F. D. O., Vairo, F. P. E., Burin, M. G., Michelin‐Tirelli, K., Brusius‐Facchin, A. C., Kubaski, F., de Souza, C. F. M., Baldo, G., & Giugliani, R. (2019) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2018-0159 · Cited by 64

THE BIOSYNTHESIS OF ANIMAL GLYCOPROTEINS

Schachter, H., & Rodén, L. (1973) · Elsevier eBooks · doi:10.1016/b978-0-12-257603-4.50008-2 · Cited by 59

Autonomic Denervation of Lymphoid Organs Leads to Epigenetic Immune Atrophy in a Mouse Model of Krabbe Disease

Galbiati, F., Basso, V., Cantuti‐Castelvetri, L., Givogri, M. I., Lopez‐Rosas, A., Perez, N., Vasu, C., Cao, H., van Breemen, R. B., Mondino, A., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.3379-07.2007 · Cited by 58

Ultrastructure of Cultured Fibroblasts in I-Cell Disease

Hanai, J. (1971) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1971.02110010070011 · Cited by 55

Axons mediate the distribution of arylsulfatase a within the mouse hippocampus upon gene delivery

Luca, T., Givogri, M. I., Perani, L., Galbiati, F., Follenzi, A., Naldini, L., & Bongarzone, E. R. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.06.438 · Cited by 54

Targeting macrophages with baculovirus‐produced lysosomal enzymes: implications for enzyme replacement therapy of the glycoprotein storage disorder galactosialidosis

Bonten, E. J., Wang, D., Toy, J. N., Mann, L., Mignardot, A., Yogalingam, G., & d'Azzo, A. (2004) · The FASEB Journal · doi:10.1096/fj.03-0941fje · Cited by 54

Simulation of Genetic Mucopolysaccharidoses in Normal Human Fibroblasts by Alteration of pH of the Medium

Lie, S. O., McKusick, V. A., & Neufeld, E. F. (1972) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.69.9.2361 · Cited by 54

Pathogenesis and therapies for infantile neuronal ceroid lipofuscinosis (infantile CLN1 disease)

Hawkins-Salsbury, J. A., Cooper, J. D., & Sands, M. S. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.05.026 · Cited by 51

The Use of Nonneuronal Cells for Gene Delivery

Snyder, E. Y., & Senut, M. (1997) · Neurobiology of Disease · doi:10.1006/nbdi.1997.0138 · Cited by 51

Enzyme replacement therapy

Neufeld, E. F. (2004) · doi:10.1093/acprof:oso/9780198508786.003.0013 · Cited by 50

Gene therapy for mucopolysaccharidoses: in vivo and ex vivo approaches

Fraldi, A., Serafini, M., Sorrentino, N. C., Gentner, B., Aiuti, A., & Bernardo, M. E. (2018) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-018-0565-y · Cited by 49

AAV-mediated intravitreal gene therapy reduces lysosomal storage in the retinal pigmented epithelium and improves retinal function in adult MPS VII mice

Hennig, A. K., Ogilvie, J. M., Ohlemiller, K. K., Timmers, A. M., Hauswirth, W. W., & Sands, M. S. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.03.018 · Cited by 49

Treatment for Krabbe's disease: Finding the combination

Mikulka, C. R., & Sands, M. S. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23822 · Cited by 48

Hematopoietic Stem Cell Transplantation to Treat Leukodystrophies: Clinical Practice Guidelines from the Hunter's Hope Leukodystrophy Care Network

Page, K. M., Stenger, E. O., Connelly, J. A., Shyr, D. C., West, T., Wood, S. J., Case, L. E., Kester, M., Shim, S., Hammond, L., et al. (2019) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2019.09.003 · Cited by 49

Umbilical cord blood transplantation for non-malignant diseases

Prasad, V. K., & Kurtzberg, J. (2009) · Bone Marrow Transplantation · doi:10.1038/bmt.2009.290 · Cited by 48

Engraftment of human CD34+ cells leads to widespread distribution of donor-derived cells and correction of tissue pathology in a novel murine xenotransplantation model of lysosomal storage disease

Hofling, A. A., Vogler, C. A., Creer, M. H., & Sands, M. S. (2003) · Blood · doi:10.1182/blood-2002-08-2597 · Cited by 47

Animal models for mucopolysaccharidoses and their clinical relevance

Haskins, M. E., Casal, M. L., Ellinwood, N. M., Melniczek, J. R., Mazrier, H., & Giger, U. (2002) · Acta Paediatrica · doi:10.1080/080352502762458003 · Cited by 48

Bone marrow transplantation increases efficacy of central nervous system-directed enzyme replacement therapy in the murine model of globoid cell leukodystrophy

Qin, E. Y., Hawkins-Salsbury, J. A., Jiang, X., Reddy, A. S., Farber, N. B., Ory, D. S., & Sands, M. S. (2012) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2012.05.021 · Cited by 46

Human CD34+ hematopoietic progenitor cell-directed lentiviral-mediated gene therapy in a xenotransplantation model of lysosomal storage disease.

Hofling, A., Devine, S., Vogler, C., & Sands, M. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.03.013 · Cited by 48

Disturbance of perineuronal nets in the perilesional area after photothrombosis is not associated with neuronal death

Karetko-Sysa, M., Skangiel-Kramska, J., & Nowicka, D. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.05.022 · Cited by 45

Abnormal osteoclast morphology and bone remodeling in a murine model of a lysosomal storage disease

Monroy, M. A., Ross, F. P., Teitelbaum, S. L., & Sands, M. S. (2002) · Bone · doi:10.1016/s8756-3282(01)00679-2 · Cited by 45

Partial Correction of the CNS Lysosomal Storage Defect in a Mouse Model of Juvenile Neuronal Ceroid Lipofuscinosis by Neonatal CNS Administration of an Adeno-Associated Virus Serotype rh.10 Vector Expressing the Human CLN3 Gene

Sondhi, D., Scott, E., Chen, A., Hackett, N. R., Wong, A. M. S., Kubiak, A., Nelvagal, H. R., Pearse, Y., Cotman, S. L., Cooper, J. D., et al. (2013) · Human Gene Therapy · doi:10.1089/hum.2012.253 · Cited by 44

Spondyloepiphyseal dysplasia, chondroitin sulfate type: A possible defect of paps — Chondroitin sulfate sulfotransferase in humans

Mourão, P. A. S., Kato, S., & Donnelly, P. V. (1981) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(81)90852-4 · Cited by 43

Collagen Pathology at the Molecular Level

Lapiere, C. M., & Nusgens, B. (1976) · Springer eBooks · doi:10.1007/978-1-4757-4602-0_8 · Cited by 41

A distinct biochemical deficit in the maroteaux-lamy syndrome (mucopolysaccharidosis VI)

Barton, R. W., & Neufeld, E. F. (1972) · The Journal of Pediatrics · doi:10.1016/s0022-3476(72)80467-0 · Cited by 42

Mechanisms of demyelination and neurodegeneration in globoid cell leukodystrophy

Feltri, M. L., Weinstock, N. I., Favret, J., Dhimal, N., Wrabetz, L. G., & Shin, D. (2021) · Glia · doi:10.1002/glia.24008 · Cited by 39

Multipotential Neural Precursors Transplanted into the Metachromatic Leukodystrophy Brain Fail to Generate Oligodendrocytes but Contribute to Limit Brain Dysfunction

Givogri, M. I., Bottai, D., Zhu, H., Fasano, S., Lamorte, G., Brambilla, R., Vescovi, A. L., Wrabetz, L. G., & Bongarzone, E. R. (2008) · Developmental Neuroscience · doi:10.1159/000150127 · Cited by 37

Behavior and Therapeutic Efficacy of β-Glucuronidase–Positive Mononuclear Phagocytes in a Murine Model of Mucopolysaccharidosis Type VII

Freeman, B. J., Roberts, M. S., Vogler, C. A., Nicholes, A., Hofling, A. A., & Sands, M. S. (1999) · Blood · doi:10.1182/blood.v94.6.2142 · Cited by 39

Feasibility of Gene Therapy for Late Neuronal Ceroid Lipofuscinosis

Sondhi, D. (2001) · Archives of Neurology · doi:10.1001/archneur.58.11.1793 · Cited by 37

Gene Transfer of Low Levels of β-Glucuronidase Corrects Hepatic Lysosomal Storage in a Large Animal Model of Mucopolysaccharidosis VII

Wolfe, J. H. N., Sands, M. S., Harel, N. Y., Weil, M. A., Parente, M. K., Polesky, A. C., Reilly, J. J., Hasson, C., Weimelt, S., & Haskins, M. E. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0202 · Cited by 36

Current therapies for the soluble lysosomal forms of neuronal ceroid lipofuscinosis

Wong, A. M. S., Rahim, A. A., Waddington, S. N., & Cooper, J. D. (2010) · Biochemical Society Transactions · doi:10.1042/bst0381484 · Cited by 35

Phenotypic diversity of human diseases resulting from allelic series.

Va, M. (1973) · Europe PMC (PubMed Central) · Cited by 34

Clinical response to persistent, low‐level β‐glucuronidase expression in the murine model of mucopolysaccharidosis type VII

Donsante, A., Levy, B. K., Vogler, C., & Sands, M. S. (2007) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-007-0483-4 · Cited by 34

Inner ear pathology in the mucopolysaccharidosis VII mouse

Ohlemiller, K. K., Hennig, A. K., Lett, J. M., Heidbreder, A. F., & Sands, M. S. (2002) · Hearing Research · doi:10.1016/s0378-5955(02)00341-6 · Cited by 34

Design and optimization of lentiviral vectors for transfer of GALC expression in Twitcher brain

Dolcetta, D., Perani, L., Givogri, M. I., Galbiati, F., Amadio, S., Carro, U. D., Finocchiaro, G., Fanzani, A., Marchesini, S., Naldini, L., et al. (2006) · The Journal of Gene Medicine · doi:10.1002/jgm.924 · Cited by 33

The mucopolysaccharidoses and related conditions

Eggli, K. D., & Dorst, J. P. (1986) · Seminars in Roentgenology · doi:10.1016/0037-198x(86)90039-8 · Cited by 33

Delivery of recombinant gene product to canine brain with the use of microencapsulation

Barsoum, S. C., Milgram, N. W., MacKay, W. A., Coblentz, C. L., Delaney, K. H., Kwiecień, J. M., Kruth, S. A., & Chang, P. L. (2003) · Journal of Laboratory and Clinical Medicine · doi:10.1016/j.lab.2003.07.002 · Cited by 32

Lead concentrations in the newborn infant

Rajegowda, B. K., Glass, L., & Evans, H. E. (1972) · The Journal of Pediatrics · doi:10.1016/s0022-3476(72)80468-2 · Cited by 32

BIOSYNTHESIS OF ACIDIC GLYCOSAMINOGLYCANS: Mucopolysaccharides

Rodén, L. (1970) · Elsevier eBooks · doi:10.1016/b978-0-12-257602-7.50014-7 · Cited by 35

Neonatal brain-directed gene therapy rescues a mouse model of neurodegenerative CLN6 Batten disease

Holthaus, S.-M. K., Herranz-Martín, S., Massaro, G., Aristorena, M., Hoke, J., Hughes, M. P., Maswood, R. N., Semenyuk, O., Basche, M., Shah, A. Z., et al. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz210 · Cited by 31

Effects of bone marrow transplantation on the cardiovascular abnormalities in canine mucopolysaccharidosis VII

Sammarco, C. D., Weil, M. A., Just, C. A., Weimelt, S., Hasson, C., O’Malley, T. M., Evans, S. M., Wang, P., Casal, M., Wolfe, J. H. N., et al. (2000) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1702448 · Cited by 31

Inborn Errors of Metabolism

(2001) · Molecular Therapy · doi:10.1006/mthe.2001.0396 · Cited by 681

[Mucopolysaccharidoses].

Lenoch, F. (1970) · PubMed

[The mucopolysaccharidoses].

van Gelderen, H. H. (1971) · PubMed

[Mucopolysaccharidosis].

MAROTEAUX, P. (1977) · PubMed

[Inborn errors of metabolism at the molecular level].

Nakajima, H. (1968) · PubMed